Healthcare provider profile · identity verified

William Boehm, M.D.

Internal Medicine · WAUKESHA, WI · NPI 1346213519

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	584	162
Lisinopril	Lisinopril	569	145
Atorvastatin Calcium	Atorvastatin Calcium	565	161
Pantoprazole Sodium	Pantoprazole Sodium	331	90
Levothyroxine Sodium	Levothyroxine Sodium	280	65
Tamsulosin Hcl	Tamsulosin Hcl	246	71
Simvastatin	Simvastatin	244	65
Eliquis	Apixaban	210	38
Valsartan	Valsartan	193	50
Hydrochlorothiazide	Hydrochlorothiazide	190	54
Omeprazole	Omeprazole	190	54
Gabapentin	Gabapentin	189	49
Metformin Hcl Er	Metformin Hcl	175	53
Metoprolol Succinate	Metoprolol Succinate	164	47
Losartan Potassium	Losartan Potassium	156	42
Rosuvastatin Calcium	Rosuvastatin Calcium	156	45
Trazodone Hcl	Trazodone Hcl	145	32
Metformin Hcl	Metformin Hcl	144	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	135	36
Allopurinol	Allopurinol	133	33
Tramadol Hcl	Tramadol Hcl	129	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	22
Zolpidem Tartrate	Zolpidem Tartrate	116	28
Escitalopram Oxalate	Escitalopram Oxalate	111	25
Olmesartan Medoxomil	Olmesartan Medoxomil	111	28
Warfarin Sodium	Warfarin Sodium	107	28
Furosemide	Furosemide	98	33
Glimepiride	Glimepiride	93	26
Lovastatin	Lovastatin	93	23
Albuterol Sulfate Hfa	Albuterol Sulfate	91	39
Carvedilol	Carvedilol	89	24
Sertraline Hcl	Sertraline Hcl	88	22
Doxazosin Mesylate	Doxazosin Mesylate	84	24
Fenofibrate	Fenofibrate	83	20
Nifedipine Er	Nifedipine	82	21
Glipizide Er	Glipizide	72	20
Clopidogrel	Clopidogrel Bisulfate	67	21
Potassium Chloride	Potassium Chloride	66	21
Alprazolam	Alprazolam	62	suppressed
Pravastatin Sodium	Pravastatin Sodium	62	17
Prednisone	Prednisone	61	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	16
Fluoxetine Hcl	Fluoxetine Hcl	56	suppressed
Bupropion Xl	Bupropion Hcl	51	14
Atenolol	Atenolol	49	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	16
Lorazepam	Lorazepam	48	18
Montelukast Sodium	Montelukast Sodium	47	13
Finasteride	Finasteride	46	11
Spironolactone	Spironolactone	44	16
Diclofenac Sodium	Diclofenac Sodium	43	14
Meloxicam	Meloxicam	43	15
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Jardiance	Empagliflozin	42	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	12
Metoprolol Tartrate	Metoprolol Tartrate	41	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	38	11
Fluticasone Propionate	Fluticasone Propionate	36	13
Duloxetine Hcl	Duloxetine Hcl	35	11
Alendronate Sodium	Alendronate Sodium	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Glipizide	Glipizide	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	11
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	27	suppressed
Famotidine	Famotidine	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Irbesartan	Irbesartan	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Diazepam	Diazepam	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Ozempic	Semaglutide	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Azithromycin	Azithromycin	17	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	13
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Colchicine	Colchicine	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error